Global Eukaryotic Transcriptome Sequencing Market Growth (Status and Outlook) 2026-2032
The global Eukaryotic Transcriptome Sequencing market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Eukaryotic Transcriptome Sequencing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Eukaryotic Transcriptome Sequencing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Eukaryotic Transcriptome Sequencing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Eukaryotic Transcriptome Sequencing players cover Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Eukaryotic Transcriptome Sequencing Industry Forecast” looks at past sales and reviews total world Eukaryotic Transcriptome Sequencing sales in 2025, providing a comprehensive analysis by region and market sector of projected Eukaryotic Transcriptome Sequencing sales for 2026 through 2032. With Eukaryotic Transcriptome Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Eukaryotic Transcriptome Sequencing industry.
This Insight Report provides a comprehensive analysis of the global Eukaryotic Transcriptome Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Eukaryotic Transcriptome Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Eukaryotic Transcriptome Sequencing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Eukaryotic Transcriptome Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Eukaryotic Transcriptome Sequencing.
This report presents a comprehensive overview, market shares, and growth opportunities of Eukaryotic Transcriptome Sequencing market by product type, application, key players and key regions and countries.
United States market for Eukaryotic Transcriptome Sequencing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Eukaryotic Transcriptome Sequencing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Eukaryotic Transcriptome Sequencing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Eukaryotic Transcriptome Sequencing players cover Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Eukaryotic Transcriptome Sequencing Industry Forecast” looks at past sales and reviews total world Eukaryotic Transcriptome Sequencing sales in 2025, providing a comprehensive analysis by region and market sector of projected Eukaryotic Transcriptome Sequencing sales for 2026 through 2032. With Eukaryotic Transcriptome Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Eukaryotic Transcriptome Sequencing industry.
This Insight Report provides a comprehensive analysis of the global Eukaryotic Transcriptome Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Eukaryotic Transcriptome Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Eukaryotic Transcriptome Sequencing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Eukaryotic Transcriptome Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Eukaryotic Transcriptome Sequencing.
This report presents a comprehensive overview, market shares, and growth opportunities of Eukaryotic Transcriptome Sequencing market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Total RNA
- Noncoding RNA
Segmentation by Application:
- Biomedical Field
- Non-medical Field
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Illumina
- Thermo Fisher Scientific
- Bio-Rad
- Agilent Technologies
- QIAGEN
- Roche
- Pacific Biosciences
- Eurofins Scientific
- Azenta
- LabCorp
- BGI Genomics
- Zhijiang Biology
- Novogene Co., Ltd
- Macrogen
- Tsingke Biotechnology Co., Ltd.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Eukaryotic Transcriptome Sequencing Market Size (2021-2032)
2.1.2 Eukaryotic Transcriptome Sequencing Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Eukaryotic Transcriptome Sequencing by Country/Region (2021, 2025 & 2032)
2.2 Eukaryotic Transcriptome Sequencing Segment by Type
2.2.1 Total RNA
2.2.2 Noncoding RNA
2.2.3 Eukaryotic Transcriptome Sequencing Market Size by Type
2.2.3.1 Eukaryotic Transcriptome Sequencing Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Eukaryotic Transcriptome Sequencing Market Size Market Share by Type (2021-2026)
2.3 Eukaryotic Transcriptome Sequencing Segment by Application
2.3.1 Biomedical Field
2.3.2 Non-medical Field
2.3.3 Eukaryotic Transcriptome Sequencing Market Size by Application
2.3.3.1 Eukaryotic Transcriptome Sequencing Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Eukaryotic Transcriptome Sequencing Market Size Market Share by Application (2021-2026)
3 EUKARYOTIC TRANSCRIPTOME SEQUENCING MARKET SIZE BY PLAYER
3.1 Eukaryotic Transcriptome Sequencing Market Size Market Share by Player
3.1.1 Global Eukaryotic Transcriptome Sequencing Revenue by Player (2021-2026)
3.1.2 Global Eukaryotic Transcriptome Sequencing Revenue Market Share by Player (2021-2026)
3.2 Global Eukaryotic Transcriptome Sequencing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 EUKARYOTIC TRANSCRIPTOME SEQUENCING BY REGION
4.1 Eukaryotic Transcriptome Sequencing Market Size by Region (2021-2026)
4.2 Global Eukaryotic Transcriptome Sequencing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Eukaryotic Transcriptome Sequencing Market Size Growth (2021-2026)
4.4 APAC Eukaryotic Transcriptome Sequencing Market Size Growth (2021-2026)
4.5 Europe Eukaryotic Transcriptome Sequencing Market Size Growth (2021-2026)
4.6 Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Eukaryotic Transcriptome Sequencing Market Size by Country (2021-2026)
5.2 Americas Eukaryotic Transcriptome Sequencing Market Size by Type (2021-2026)
5.3 Americas Eukaryotic Transcriptome Sequencing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Eukaryotic Transcriptome Sequencing Market Size by Region (2021-2026)
6.2 APAC Eukaryotic Transcriptome Sequencing Market Size by Type (2021-2026)
6.3 APAC Eukaryotic Transcriptome Sequencing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Eukaryotic Transcriptome Sequencing Market Size by Country (2021-2026)
7.2 Europe Eukaryotic Transcriptome Sequencing Market Size by Type (2021-2026)
7.3 Europe Eukaryotic Transcriptome Sequencing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Eukaryotic Transcriptome Sequencing by Region (2021-2026)
8.2 Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size by Type (2021-2026)
8.3 Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL EUKARYOTIC TRANSCRIPTOME SEQUENCING MARKET FORECAST
10.1 Global Eukaryotic Transcriptome Sequencing Forecast by Region (2027-2032)
10.1.1 Global Eukaryotic Transcriptome Sequencing Forecast by Region (2027-2032)
10.1.2 Americas Eukaryotic Transcriptome Sequencing Forecast
10.1.3 APAC Eukaryotic Transcriptome Sequencing Forecast
10.1.4 Europe Eukaryotic Transcriptome Sequencing Forecast
10.1.5 Middle East & Africa Eukaryotic Transcriptome Sequencing Forecast
10.2 Americas Eukaryotic Transcriptome Sequencing Forecast by Country (2027-2032)
10.2.1 United States Market Eukaryotic Transcriptome Sequencing Forecast
10.2.2 Canada Market Eukaryotic Transcriptome Sequencing Forecast
10.2.3 Mexico Market Eukaryotic Transcriptome Sequencing Forecast
10.2.4 Brazil Market Eukaryotic Transcriptome Sequencing Forecast
10.3 APAC Eukaryotic Transcriptome Sequencing Forecast by Region (2027-2032)
10.3.1 China Eukaryotic Transcriptome Sequencing Market Forecast
10.3.2 Japan Market Eukaryotic Transcriptome Sequencing Forecast
10.3.3 Korea Market Eukaryotic Transcriptome Sequencing Forecast
10.3.4 Southeast Asia Market Eukaryotic Transcriptome Sequencing Forecast
10.3.5 India Market Eukaryotic Transcriptome Sequencing Forecast
10.3.6 Australia Market Eukaryotic Transcriptome Sequencing Forecast
10.4 Europe Eukaryotic Transcriptome Sequencing Forecast by Country (2027-2032)
10.4.1 Germany Market Eukaryotic Transcriptome Sequencing Forecast
10.4.2 France Market Eukaryotic Transcriptome Sequencing Forecast
10.4.3 UK Market Eukaryotic Transcriptome Sequencing Forecast
10.4.4 Italy Market Eukaryotic Transcriptome Sequencing Forecast
10.4.5 Russia Market Eukaryotic Transcriptome Sequencing Forecast
10.5 Middle East & Africa Eukaryotic Transcriptome Sequencing Forecast by Region (2027-2032)
10.5.1 Egypt Market Eukaryotic Transcriptome Sequencing Forecast
10.5.2 South Africa Market Eukaryotic Transcriptome Sequencing Forecast
10.5.3 Israel Market Eukaryotic Transcriptome Sequencing Forecast
10.5.4 Turkey Market Eukaryotic Transcriptome Sequencing Forecast
10.6 Global Eukaryotic Transcriptome Sequencing Forecast by Type (2027-2032)
10.7 Global Eukaryotic Transcriptome Sequencing Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Eukaryotic Transcriptome Sequencing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Illumina
11.1.1 Illumina Company Information
11.1.2 Illumina Eukaryotic Transcriptome Sequencing Product Offered
11.1.3 Illumina Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Illumina Main Business Overview
11.1.5 Illumina Latest Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific Eukaryotic Transcriptome Sequencing Product Offered
11.2.3 Thermo Fisher Scientific Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Thermo Fisher Scientific Main Business Overview
11.2.5 Thermo Fisher Scientific Latest Developments
11.3 Bio-Rad
11.3.1 Bio-Rad Company Information
11.3.2 Bio-Rad Eukaryotic Transcriptome Sequencing Product Offered
11.3.3 Bio-Rad Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Bio-Rad Main Business Overview
11.3.5 Bio-Rad Latest Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Information
11.4.2 Agilent Technologies Eukaryotic Transcriptome Sequencing Product Offered
11.4.3 Agilent Technologies Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Agilent Technologies Main Business Overview
11.4.5 Agilent Technologies Latest Developments
11.5 QIAGEN
11.5.1 QIAGEN Company Information
11.5.2 QIAGEN Eukaryotic Transcriptome Sequencing Product Offered
11.5.3 QIAGEN Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 QIAGEN Main Business Overview
11.5.5 QIAGEN Latest Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche Eukaryotic Transcriptome Sequencing Product Offered
11.6.3 Roche Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Roche Main Business Overview
11.6.5 Roche Latest Developments
11.7 Pacific Biosciences
11.7.1 Pacific Biosciences Company Information
11.7.2 Pacific Biosciences Eukaryotic Transcriptome Sequencing Product Offered
11.7.3 Pacific Biosciences Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Pacific Biosciences Main Business Overview
11.7.5 Pacific Biosciences Latest Developments
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Information
11.8.2 Eurofins Scientific Eukaryotic Transcriptome Sequencing Product Offered
11.8.3 Eurofins Scientific Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Eurofins Scientific Main Business Overview
11.8.5 Eurofins Scientific Latest Developments
11.9 Azenta
11.9.1 Azenta Company Information
11.9.2 Azenta Eukaryotic Transcriptome Sequencing Product Offered
11.9.3 Azenta Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Azenta Main Business Overview
11.9.5 Azenta Latest Developments
11.10 LabCorp
11.10.1 LabCorp Company Information
11.10.2 LabCorp Eukaryotic Transcriptome Sequencing Product Offered
11.10.3 LabCorp Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 LabCorp Main Business Overview
11.10.5 LabCorp Latest Developments
11.11 BGI Genomics
11.11.1 BGI Genomics Company Information
11.11.2 BGI Genomics Eukaryotic Transcriptome Sequencing Product Offered
11.11.3 BGI Genomics Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 BGI Genomics Main Business Overview
11.11.5 BGI Genomics Latest Developments
11.12 Zhijiang Biology
11.12.1 Zhijiang Biology Company Information
11.12.2 Zhijiang Biology Eukaryotic Transcriptome Sequencing Product Offered
11.12.3 Zhijiang Biology Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Zhijiang Biology Main Business Overview
11.12.5 Zhijiang Biology Latest Developments
11.13 Novogene Co., Ltd
11.13.1 Novogene Co., Ltd Company Information
11.13.2 Novogene Co., Ltd Eukaryotic Transcriptome Sequencing Product Offered
11.13.3 Novogene Co., Ltd Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Novogene Co., Ltd Main Business Overview
11.13.5 Novogene Co., Ltd Latest Developments
11.14 Macrogen
11.14.1 Macrogen Company Information
11.14.2 Macrogen Eukaryotic Transcriptome Sequencing Product Offered
11.14.3 Macrogen Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Macrogen Main Business Overview
11.14.5 Macrogen Latest Developments
11.15 Tsingke Biotechnology Co., Ltd.
11.15.1 Tsingke Biotechnology Co., Ltd. Company Information
11.15.2 Tsingke Biotechnology Co., Ltd. Eukaryotic Transcriptome Sequencing Product Offered
11.15.3 Tsingke Biotechnology Co., Ltd. Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Tsingke Biotechnology Co., Ltd. Main Business Overview
11.15.5 Tsingke Biotechnology Co., Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Eukaryotic Transcriptome Sequencing Market Size (2021-2032)
2.1.2 Eukaryotic Transcriptome Sequencing Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Eukaryotic Transcriptome Sequencing by Country/Region (2021, 2025 & 2032)
2.2 Eukaryotic Transcriptome Sequencing Segment by Type
2.2.1 Total RNA
2.2.2 Noncoding RNA
2.2.3 Eukaryotic Transcriptome Sequencing Market Size by Type
2.2.3.1 Eukaryotic Transcriptome Sequencing Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Eukaryotic Transcriptome Sequencing Market Size Market Share by Type (2021-2026)
2.3 Eukaryotic Transcriptome Sequencing Segment by Application
2.3.1 Biomedical Field
2.3.2 Non-medical Field
2.3.3 Eukaryotic Transcriptome Sequencing Market Size by Application
2.3.3.1 Eukaryotic Transcriptome Sequencing Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Eukaryotic Transcriptome Sequencing Market Size Market Share by Application (2021-2026)
3 EUKARYOTIC TRANSCRIPTOME SEQUENCING MARKET SIZE BY PLAYER
3.1 Eukaryotic Transcriptome Sequencing Market Size Market Share by Player
3.1.1 Global Eukaryotic Transcriptome Sequencing Revenue by Player (2021-2026)
3.1.2 Global Eukaryotic Transcriptome Sequencing Revenue Market Share by Player (2021-2026)
3.2 Global Eukaryotic Transcriptome Sequencing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 EUKARYOTIC TRANSCRIPTOME SEQUENCING BY REGION
4.1 Eukaryotic Transcriptome Sequencing Market Size by Region (2021-2026)
4.2 Global Eukaryotic Transcriptome Sequencing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Eukaryotic Transcriptome Sequencing Market Size Growth (2021-2026)
4.4 APAC Eukaryotic Transcriptome Sequencing Market Size Growth (2021-2026)
4.5 Europe Eukaryotic Transcriptome Sequencing Market Size Growth (2021-2026)
4.6 Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Eukaryotic Transcriptome Sequencing Market Size by Country (2021-2026)
5.2 Americas Eukaryotic Transcriptome Sequencing Market Size by Type (2021-2026)
5.3 Americas Eukaryotic Transcriptome Sequencing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Eukaryotic Transcriptome Sequencing Market Size by Region (2021-2026)
6.2 APAC Eukaryotic Transcriptome Sequencing Market Size by Type (2021-2026)
6.3 APAC Eukaryotic Transcriptome Sequencing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Eukaryotic Transcriptome Sequencing Market Size by Country (2021-2026)
7.2 Europe Eukaryotic Transcriptome Sequencing Market Size by Type (2021-2026)
7.3 Europe Eukaryotic Transcriptome Sequencing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Eukaryotic Transcriptome Sequencing by Region (2021-2026)
8.2 Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size by Type (2021-2026)
8.3 Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL EUKARYOTIC TRANSCRIPTOME SEQUENCING MARKET FORECAST
10.1 Global Eukaryotic Transcriptome Sequencing Forecast by Region (2027-2032)
10.1.1 Global Eukaryotic Transcriptome Sequencing Forecast by Region (2027-2032)
10.1.2 Americas Eukaryotic Transcriptome Sequencing Forecast
10.1.3 APAC Eukaryotic Transcriptome Sequencing Forecast
10.1.4 Europe Eukaryotic Transcriptome Sequencing Forecast
10.1.5 Middle East & Africa Eukaryotic Transcriptome Sequencing Forecast
10.2 Americas Eukaryotic Transcriptome Sequencing Forecast by Country (2027-2032)
10.2.1 United States Market Eukaryotic Transcriptome Sequencing Forecast
10.2.2 Canada Market Eukaryotic Transcriptome Sequencing Forecast
10.2.3 Mexico Market Eukaryotic Transcriptome Sequencing Forecast
10.2.4 Brazil Market Eukaryotic Transcriptome Sequencing Forecast
10.3 APAC Eukaryotic Transcriptome Sequencing Forecast by Region (2027-2032)
10.3.1 China Eukaryotic Transcriptome Sequencing Market Forecast
10.3.2 Japan Market Eukaryotic Transcriptome Sequencing Forecast
10.3.3 Korea Market Eukaryotic Transcriptome Sequencing Forecast
10.3.4 Southeast Asia Market Eukaryotic Transcriptome Sequencing Forecast
10.3.5 India Market Eukaryotic Transcriptome Sequencing Forecast
10.3.6 Australia Market Eukaryotic Transcriptome Sequencing Forecast
10.4 Europe Eukaryotic Transcriptome Sequencing Forecast by Country (2027-2032)
10.4.1 Germany Market Eukaryotic Transcriptome Sequencing Forecast
10.4.2 France Market Eukaryotic Transcriptome Sequencing Forecast
10.4.3 UK Market Eukaryotic Transcriptome Sequencing Forecast
10.4.4 Italy Market Eukaryotic Transcriptome Sequencing Forecast
10.4.5 Russia Market Eukaryotic Transcriptome Sequencing Forecast
10.5 Middle East & Africa Eukaryotic Transcriptome Sequencing Forecast by Region (2027-2032)
10.5.1 Egypt Market Eukaryotic Transcriptome Sequencing Forecast
10.5.2 South Africa Market Eukaryotic Transcriptome Sequencing Forecast
10.5.3 Israel Market Eukaryotic Transcriptome Sequencing Forecast
10.5.4 Turkey Market Eukaryotic Transcriptome Sequencing Forecast
10.6 Global Eukaryotic Transcriptome Sequencing Forecast by Type (2027-2032)
10.7 Global Eukaryotic Transcriptome Sequencing Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Eukaryotic Transcriptome Sequencing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Illumina
11.1.1 Illumina Company Information
11.1.2 Illumina Eukaryotic Transcriptome Sequencing Product Offered
11.1.3 Illumina Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Illumina Main Business Overview
11.1.5 Illumina Latest Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific Eukaryotic Transcriptome Sequencing Product Offered
11.2.3 Thermo Fisher Scientific Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Thermo Fisher Scientific Main Business Overview
11.2.5 Thermo Fisher Scientific Latest Developments
11.3 Bio-Rad
11.3.1 Bio-Rad Company Information
11.3.2 Bio-Rad Eukaryotic Transcriptome Sequencing Product Offered
11.3.3 Bio-Rad Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Bio-Rad Main Business Overview
11.3.5 Bio-Rad Latest Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Information
11.4.2 Agilent Technologies Eukaryotic Transcriptome Sequencing Product Offered
11.4.3 Agilent Technologies Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Agilent Technologies Main Business Overview
11.4.5 Agilent Technologies Latest Developments
11.5 QIAGEN
11.5.1 QIAGEN Company Information
11.5.2 QIAGEN Eukaryotic Transcriptome Sequencing Product Offered
11.5.3 QIAGEN Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 QIAGEN Main Business Overview
11.5.5 QIAGEN Latest Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche Eukaryotic Transcriptome Sequencing Product Offered
11.6.3 Roche Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Roche Main Business Overview
11.6.5 Roche Latest Developments
11.7 Pacific Biosciences
11.7.1 Pacific Biosciences Company Information
11.7.2 Pacific Biosciences Eukaryotic Transcriptome Sequencing Product Offered
11.7.3 Pacific Biosciences Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Pacific Biosciences Main Business Overview
11.7.5 Pacific Biosciences Latest Developments
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Information
11.8.2 Eurofins Scientific Eukaryotic Transcriptome Sequencing Product Offered
11.8.3 Eurofins Scientific Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Eurofins Scientific Main Business Overview
11.8.5 Eurofins Scientific Latest Developments
11.9 Azenta
11.9.1 Azenta Company Information
11.9.2 Azenta Eukaryotic Transcriptome Sequencing Product Offered
11.9.3 Azenta Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Azenta Main Business Overview
11.9.5 Azenta Latest Developments
11.10 LabCorp
11.10.1 LabCorp Company Information
11.10.2 LabCorp Eukaryotic Transcriptome Sequencing Product Offered
11.10.3 LabCorp Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 LabCorp Main Business Overview
11.10.5 LabCorp Latest Developments
11.11 BGI Genomics
11.11.1 BGI Genomics Company Information
11.11.2 BGI Genomics Eukaryotic Transcriptome Sequencing Product Offered
11.11.3 BGI Genomics Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 BGI Genomics Main Business Overview
11.11.5 BGI Genomics Latest Developments
11.12 Zhijiang Biology
11.12.1 Zhijiang Biology Company Information
11.12.2 Zhijiang Biology Eukaryotic Transcriptome Sequencing Product Offered
11.12.3 Zhijiang Biology Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Zhijiang Biology Main Business Overview
11.12.5 Zhijiang Biology Latest Developments
11.13 Novogene Co., Ltd
11.13.1 Novogene Co., Ltd Company Information
11.13.2 Novogene Co., Ltd Eukaryotic Transcriptome Sequencing Product Offered
11.13.3 Novogene Co., Ltd Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Novogene Co., Ltd Main Business Overview
11.13.5 Novogene Co., Ltd Latest Developments
11.14 Macrogen
11.14.1 Macrogen Company Information
11.14.2 Macrogen Eukaryotic Transcriptome Sequencing Product Offered
11.14.3 Macrogen Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Macrogen Main Business Overview
11.14.5 Macrogen Latest Developments
11.15 Tsingke Biotechnology Co., Ltd.
11.15.1 Tsingke Biotechnology Co., Ltd. Company Information
11.15.2 Tsingke Biotechnology Co., Ltd. Eukaryotic Transcriptome Sequencing Product Offered
11.15.3 Tsingke Biotechnology Co., Ltd. Eukaryotic Transcriptome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Tsingke Biotechnology Co., Ltd. Main Business Overview
11.15.5 Tsingke Biotechnology Co., Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Eukaryotic Transcriptome Sequencing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Eukaryotic Transcriptome Sequencing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Total RNA
Table 4. Major Players of Noncoding RNA
Table 5. Eukaryotic Transcriptome Sequencing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Eukaryotic Transcriptome Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Eukaryotic Transcriptome Sequencing Market Size Market Share by Type (2021-2026)
Table 8. Eukaryotic Transcriptome Sequencing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Eukaryotic Transcriptome Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Eukaryotic Transcriptome Sequencing Market Size Market Share by Application (2021-2026)
Table 11. Global Eukaryotic Transcriptome Sequencing Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Eukaryotic Transcriptome Sequencing Revenue Market Share by Player (2021-2026)
Table 13. Eukaryotic Transcriptome Sequencing Key Players Head office and Products Offered
Table 14. Eukaryotic Transcriptome Sequencing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Eukaryotic Transcriptome Sequencing Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Eukaryotic Transcriptome Sequencing Market Size Market Share by Region (2021-2026)
Table 19. Global Eukaryotic Transcriptome Sequencing Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Eukaryotic Transcriptome Sequencing Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Eukaryotic Transcriptome Sequencing Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Eukaryotic Transcriptome Sequencing Market Size Market Share by Country (2021-2026)
Table 23. Americas Eukaryotic Transcriptome Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Eukaryotic Transcriptome Sequencing Market Size Market Share by Type (2021-2026)
Table 25. Americas Eukaryotic Transcriptome Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Eukaryotic Transcriptome Sequencing Market Size Market Share by Application (2021-2026)
Table 27. APAC Eukaryotic Transcriptome Sequencing Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Eukaryotic Transcriptome Sequencing Market Size Market Share by Region (2021-2026)
Table 29. APAC Eukaryotic Transcriptome Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Eukaryotic Transcriptome Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Eukaryotic Transcriptome Sequencing Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Eukaryotic Transcriptome Sequencing Market Size Market Share by Country (2021-2026)
Table 33. Europe Eukaryotic Transcriptome Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Eukaryotic Transcriptome Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Eukaryotic Transcriptome Sequencing
Table 39. Key Market Challenges & Risks of Eukaryotic Transcriptome Sequencing
Table 40. Key Industry Trends of Eukaryotic Transcriptome Sequencing
Table 41. Global Eukaryotic Transcriptome Sequencing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Eukaryotic Transcriptome Sequencing Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Eukaryotic Transcriptome Sequencing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Eukaryotic Transcriptome Sequencing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Illumina Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 46. Illumina Eukaryotic Transcriptome Sequencing Product Offered
Table 47. Illumina Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Illumina Main Business
Table 49. Illumina Latest Developments
Table 50. Thermo Fisher Scientific Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 51. Thermo Fisher Scientific Eukaryotic Transcriptome Sequencing Product Offered
Table 52. Thermo Fisher Scientific Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Thermo Fisher Scientific Main Business
Table 54. Thermo Fisher Scientific Latest Developments
Table 55. Bio-Rad Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 56. Bio-Rad Eukaryotic Transcriptome Sequencing Product Offered
Table 57. Bio-Rad Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Bio-Rad Main Business
Table 59. Bio-Rad Latest Developments
Table 60. Agilent Technologies Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 61. Agilent Technologies Eukaryotic Transcriptome Sequencing Product Offered
Table 62. Agilent Technologies Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Agilent Technologies Main Business
Table 64. Agilent Technologies Latest Developments
Table 65. QIAGEN Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 66. QIAGEN Eukaryotic Transcriptome Sequencing Product Offered
Table 67. QIAGEN Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. QIAGEN Main Business
Table 69. QIAGEN Latest Developments
Table 70. Roche Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 71. Roche Eukaryotic Transcriptome Sequencing Product Offered
Table 72. Roche Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Roche Main Business
Table 74. Roche Latest Developments
Table 75. Pacific Biosciences Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 76. Pacific Biosciences Eukaryotic Transcriptome Sequencing Product Offered
Table 77. Pacific Biosciences Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Pacific Biosciences Main Business
Table 79. Pacific Biosciences Latest Developments
Table 80. Eurofins Scientific Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 81. Eurofins Scientific Eukaryotic Transcriptome Sequencing Product Offered
Table 82. Eurofins Scientific Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Eurofins Scientific Main Business
Table 84. Eurofins Scientific Latest Developments
Table 85. Azenta Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 86. Azenta Eukaryotic Transcriptome Sequencing Product Offered
Table 87. Azenta Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Azenta Main Business
Table 89. Azenta Latest Developments
Table 90. LabCorp Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 91. LabCorp Eukaryotic Transcriptome Sequencing Product Offered
Table 92. LabCorp Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. LabCorp Main Business
Table 94. LabCorp Latest Developments
Table 95. BGI Genomics Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 96. BGI Genomics Eukaryotic Transcriptome Sequencing Product Offered
Table 97. BGI Genomics Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. BGI Genomics Main Business
Table 99. BGI Genomics Latest Developments
Table 100. Zhijiang Biology Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 101. Zhijiang Biology Eukaryotic Transcriptome Sequencing Product Offered
Table 102. Zhijiang Biology Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Zhijiang Biology Main Business
Table 104. Zhijiang Biology Latest Developments
Table 105. Novogene Co., Ltd Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 106. Novogene Co., Ltd Eukaryotic Transcriptome Sequencing Product Offered
Table 107. Novogene Co., Ltd Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Novogene Co., Ltd Main Business
Table 109. Novogene Co., Ltd Latest Developments
Table 110. Macrogen Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 111. Macrogen Eukaryotic Transcriptome Sequencing Product Offered
Table 112. Macrogen Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Macrogen Main Business
Table 114. Macrogen Latest Developments
Table 115. Tsingke Biotechnology Co., Ltd. Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 116. Tsingke Biotechnology Co., Ltd. Eukaryotic Transcriptome Sequencing Product Offered
Table 117. Tsingke Biotechnology Co., Ltd. Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Tsingke Biotechnology Co., Ltd. Main Business
Table 119. Tsingke Biotechnology Co., Ltd. Latest Developments
Table 1. Eukaryotic Transcriptome Sequencing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Eukaryotic Transcriptome Sequencing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Total RNA
Table 4. Major Players of Noncoding RNA
Table 5. Eukaryotic Transcriptome Sequencing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Eukaryotic Transcriptome Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Eukaryotic Transcriptome Sequencing Market Size Market Share by Type (2021-2026)
Table 8. Eukaryotic Transcriptome Sequencing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Eukaryotic Transcriptome Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Eukaryotic Transcriptome Sequencing Market Size Market Share by Application (2021-2026)
Table 11. Global Eukaryotic Transcriptome Sequencing Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Eukaryotic Transcriptome Sequencing Revenue Market Share by Player (2021-2026)
Table 13. Eukaryotic Transcriptome Sequencing Key Players Head office and Products Offered
Table 14. Eukaryotic Transcriptome Sequencing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Eukaryotic Transcriptome Sequencing Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Eukaryotic Transcriptome Sequencing Market Size Market Share by Region (2021-2026)
Table 19. Global Eukaryotic Transcriptome Sequencing Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Eukaryotic Transcriptome Sequencing Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Eukaryotic Transcriptome Sequencing Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Eukaryotic Transcriptome Sequencing Market Size Market Share by Country (2021-2026)
Table 23. Americas Eukaryotic Transcriptome Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Eukaryotic Transcriptome Sequencing Market Size Market Share by Type (2021-2026)
Table 25. Americas Eukaryotic Transcriptome Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Eukaryotic Transcriptome Sequencing Market Size Market Share by Application (2021-2026)
Table 27. APAC Eukaryotic Transcriptome Sequencing Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Eukaryotic Transcriptome Sequencing Market Size Market Share by Region (2021-2026)
Table 29. APAC Eukaryotic Transcriptome Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Eukaryotic Transcriptome Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Eukaryotic Transcriptome Sequencing Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Eukaryotic Transcriptome Sequencing Market Size Market Share by Country (2021-2026)
Table 33. Europe Eukaryotic Transcriptome Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Eukaryotic Transcriptome Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Eukaryotic Transcriptome Sequencing
Table 39. Key Market Challenges & Risks of Eukaryotic Transcriptome Sequencing
Table 40. Key Industry Trends of Eukaryotic Transcriptome Sequencing
Table 41. Global Eukaryotic Transcriptome Sequencing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Eukaryotic Transcriptome Sequencing Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Eukaryotic Transcriptome Sequencing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Eukaryotic Transcriptome Sequencing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Illumina Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 46. Illumina Eukaryotic Transcriptome Sequencing Product Offered
Table 47. Illumina Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Illumina Main Business
Table 49. Illumina Latest Developments
Table 50. Thermo Fisher Scientific Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 51. Thermo Fisher Scientific Eukaryotic Transcriptome Sequencing Product Offered
Table 52. Thermo Fisher Scientific Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Thermo Fisher Scientific Main Business
Table 54. Thermo Fisher Scientific Latest Developments
Table 55. Bio-Rad Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 56. Bio-Rad Eukaryotic Transcriptome Sequencing Product Offered
Table 57. Bio-Rad Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Bio-Rad Main Business
Table 59. Bio-Rad Latest Developments
Table 60. Agilent Technologies Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 61. Agilent Technologies Eukaryotic Transcriptome Sequencing Product Offered
Table 62. Agilent Technologies Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Agilent Technologies Main Business
Table 64. Agilent Technologies Latest Developments
Table 65. QIAGEN Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 66. QIAGEN Eukaryotic Transcriptome Sequencing Product Offered
Table 67. QIAGEN Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. QIAGEN Main Business
Table 69. QIAGEN Latest Developments
Table 70. Roche Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 71. Roche Eukaryotic Transcriptome Sequencing Product Offered
Table 72. Roche Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Roche Main Business
Table 74. Roche Latest Developments
Table 75. Pacific Biosciences Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 76. Pacific Biosciences Eukaryotic Transcriptome Sequencing Product Offered
Table 77. Pacific Biosciences Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Pacific Biosciences Main Business
Table 79. Pacific Biosciences Latest Developments
Table 80. Eurofins Scientific Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 81. Eurofins Scientific Eukaryotic Transcriptome Sequencing Product Offered
Table 82. Eurofins Scientific Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Eurofins Scientific Main Business
Table 84. Eurofins Scientific Latest Developments
Table 85. Azenta Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 86. Azenta Eukaryotic Transcriptome Sequencing Product Offered
Table 87. Azenta Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Azenta Main Business
Table 89. Azenta Latest Developments
Table 90. LabCorp Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 91. LabCorp Eukaryotic Transcriptome Sequencing Product Offered
Table 92. LabCorp Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. LabCorp Main Business
Table 94. LabCorp Latest Developments
Table 95. BGI Genomics Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 96. BGI Genomics Eukaryotic Transcriptome Sequencing Product Offered
Table 97. BGI Genomics Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. BGI Genomics Main Business
Table 99. BGI Genomics Latest Developments
Table 100. Zhijiang Biology Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 101. Zhijiang Biology Eukaryotic Transcriptome Sequencing Product Offered
Table 102. Zhijiang Biology Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Zhijiang Biology Main Business
Table 104. Zhijiang Biology Latest Developments
Table 105. Novogene Co., Ltd Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 106. Novogene Co., Ltd Eukaryotic Transcriptome Sequencing Product Offered
Table 107. Novogene Co., Ltd Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Novogene Co., Ltd Main Business
Table 109. Novogene Co., Ltd Latest Developments
Table 110. Macrogen Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 111. Macrogen Eukaryotic Transcriptome Sequencing Product Offered
Table 112. Macrogen Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Macrogen Main Business
Table 114. Macrogen Latest Developments
Table 115. Tsingke Biotechnology Co., Ltd. Details, Company Type, Eukaryotic Transcriptome Sequencing Area Served and Its Competitors
Table 116. Tsingke Biotechnology Co., Ltd. Eukaryotic Transcriptome Sequencing Product Offered
Table 117. Tsingke Biotechnology Co., Ltd. Eukaryotic Transcriptome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Tsingke Biotechnology Co., Ltd. Main Business
Table 119. Tsingke Biotechnology Co., Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Eukaryotic Transcriptome Sequencing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Eukaryotic Transcriptome Sequencing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Eukaryotic Transcriptome Sequencing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Eukaryotic Transcriptome Sequencing Sales Market Share by Country/Region (2025)
Figure 8. Eukaryotic Transcriptome Sequencing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Eukaryotic Transcriptome Sequencing Market Size Market Share by Type in 2025
Figure 10. Eukaryotic Transcriptome Sequencing in Biomedical Field
Figure 11. Global Eukaryotic Transcriptome Sequencing Market: Biomedical Field (2021-2026) & ($ millions)
Figure 12. Eukaryotic Transcriptome Sequencing in Non-medical Field
Figure 13. Global Eukaryotic Transcriptome Sequencing Market: Non-medical Field (2021-2026) & ($ millions)
Figure 14. Global Eukaryotic Transcriptome Sequencing Market Size Market Share by Application in 2025
Figure 15. Global Eukaryotic Transcriptome Sequencing Revenue Market Share by Player in 2025
Figure 16. Global Eukaryotic Transcriptome Sequencing Market Size Market Share by Region (2021-2026)
Figure 17. Americas Eukaryotic Transcriptome Sequencing Market Size 2021-2026 ($ millions)
Figure 18. APAC Eukaryotic Transcriptome Sequencing Market Size 2021-2026 ($ millions)
Figure 19. Europe Eukaryotic Transcriptome Sequencing Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size 2021-2026 ($ millions)
Figure 21. Americas Eukaryotic Transcriptome Sequencing Value Market Share by Country in 2025
Figure 22. United States Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Eukaryotic Transcriptome Sequencing Market Size Market Share by Region in 2025
Figure 27. APAC Eukaryotic Transcriptome Sequencing Market Size Market Share by Type (2021-2026)
Figure 28. APAC Eukaryotic Transcriptome Sequencing Market Size Market Share by Application (2021-2026)
Figure 29. China Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 33. India Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Eukaryotic Transcriptome Sequencing Market Size Market Share by Country in 2025
Figure 36. Europe Eukaryotic Transcriptome Sequencing Market Size Market Share by Type (2021-2026)
Figure 37. Europe Eukaryotic Transcriptome Sequencing Market Size Market Share by Application (2021-2026)
Figure 38. Germany Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 39. France Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 52. APAC Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 53. Europe Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 55. United States Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 56. Canada Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 57. Mexico Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 58. Brazil Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 59. China Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 60. Japan Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 61. Korea Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 63. India Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 64. Australia Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 65. Germany Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 66. France Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 67. UK Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 68. Italy Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 69. Russia Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 70. Egypt Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 71. South Africa Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 72. Israel Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 73. Turkey Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 74. Global Eukaryotic Transcriptome Sequencing Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Eukaryotic Transcriptome Sequencing Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 1. Eukaryotic Transcriptome Sequencing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Eukaryotic Transcriptome Sequencing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Eukaryotic Transcriptome Sequencing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Eukaryotic Transcriptome Sequencing Sales Market Share by Country/Region (2025)
Figure 8. Eukaryotic Transcriptome Sequencing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Eukaryotic Transcriptome Sequencing Market Size Market Share by Type in 2025
Figure 10. Eukaryotic Transcriptome Sequencing in Biomedical Field
Figure 11. Global Eukaryotic Transcriptome Sequencing Market: Biomedical Field (2021-2026) & ($ millions)
Figure 12. Eukaryotic Transcriptome Sequencing in Non-medical Field
Figure 13. Global Eukaryotic Transcriptome Sequencing Market: Non-medical Field (2021-2026) & ($ millions)
Figure 14. Global Eukaryotic Transcriptome Sequencing Market Size Market Share by Application in 2025
Figure 15. Global Eukaryotic Transcriptome Sequencing Revenue Market Share by Player in 2025
Figure 16. Global Eukaryotic Transcriptome Sequencing Market Size Market Share by Region (2021-2026)
Figure 17. Americas Eukaryotic Transcriptome Sequencing Market Size 2021-2026 ($ millions)
Figure 18. APAC Eukaryotic Transcriptome Sequencing Market Size 2021-2026 ($ millions)
Figure 19. Europe Eukaryotic Transcriptome Sequencing Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size 2021-2026 ($ millions)
Figure 21. Americas Eukaryotic Transcriptome Sequencing Value Market Share by Country in 2025
Figure 22. United States Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Eukaryotic Transcriptome Sequencing Market Size Market Share by Region in 2025
Figure 27. APAC Eukaryotic Transcriptome Sequencing Market Size Market Share by Type (2021-2026)
Figure 28. APAC Eukaryotic Transcriptome Sequencing Market Size Market Share by Application (2021-2026)
Figure 29. China Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 33. India Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Eukaryotic Transcriptome Sequencing Market Size Market Share by Country in 2025
Figure 36. Europe Eukaryotic Transcriptome Sequencing Market Size Market Share by Type (2021-2026)
Figure 37. Europe Eukaryotic Transcriptome Sequencing Market Size Market Share by Application (2021-2026)
Figure 38. Germany Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 39. France Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Eukaryotic Transcriptome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 52. APAC Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 53. Europe Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 55. United States Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 56. Canada Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 57. Mexico Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 58. Brazil Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 59. China Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 60. Japan Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 61. Korea Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 63. India Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 64. Australia Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 65. Germany Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 66. France Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 67. UK Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 68. Italy Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 69. Russia Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 70. Egypt Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 71. South Africa Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 72. Israel Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 73. Turkey Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
Figure 74. Global Eukaryotic Transcriptome Sequencing Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Eukaryotic Transcriptome Sequencing Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Eukaryotic Transcriptome Sequencing Market Size 2027-2032 ($ millions)
